Skip to main content

Silk Road Medical, Inc. (SILK)

NASDAQ: SILK · IEX Real-Time Price · USD
41.00 -2.83 (-6.46%)
Dec 3, 2021 4:00 PM EST - Market closed
Market Cap1.43B
Revenue (ttm)94.34M
Net Income (ttm)-51.88M
Shares Out34.90M
EPS (ttm)-1.51
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume599,931
Open43.92
Previous Close43.83
Day's Range39.82 - 44.01
52-Week Range39.82 - 67.49
Beta1.48
AnalystsBuy
Price Target62.33 (+52.0%)
Earnings DateNov 9, 2021

About SILK

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid ...

IndustryHealth Care Equipment & Supplies
IPO DateApr 4, 2019
CEOErica Rogers
Employees281
Stock ExchangeNASDAQ
Ticker SymbolSILK
Full Company Profile

Financial Performance

In 2020, SILK's revenue was $75.23 million, an increase of 18.74% compared to the previous year's $63.35 million. Losses were -$47.37 million, -9.63% less than in 2019.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for SILK stock is "Buy." The 12-month stock price forecast is 62.33, which is an increase of 52.02% from the latest price.

Price Target
$62.33
(52.02% upside)
Analyst Consensus: Buy

News

Silk Road Medical to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

SUNNYVALE, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will...

3 weeks ago - GlobeNewsWire

Silk Road Medical (SILK) Reports Q3 Loss, Lags Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of -29.03% and -5.09%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago - Zacks Investment Research

Silk Road Medical Reports Third Quarter 2021 Financial Results

SUNNYVALE, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results...

3 weeks ago - GlobeNewsWire

Silk Road Medical to Present at the Stifel 2021 Virtual Healthcare Conference

SUNNYVALE, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will...

1 month ago - GlobeNewsWire

Will Silk Road Medical (SILK) Report Negative Earnings Next Week? What You Should Know

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Silk Road Medical to Report Third Quarter 2021 Financial Results on November 9, 2021

SUNNYVALE, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report f...

1 month ago - GlobeNewsWire

Is Silk Road Medical (SILK) a Great Growth Stock?

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Silk Road Medical (SILK).

2 months ago - Zacks Investment Research

Silk Road Medical (SILK) Upgraded to Buy: Here's Why

Silk Road Medical (SILK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

2 months ago - Zacks Investment Research

Silk Road Medical to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

SUNNYVALE, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wil...

3 months ago - GlobeNewsWire

First Ever Analysis of TCAR in Standard Surgical Risk Patients Demonstrates Clinical Benefits in Large Comparative Da...

Large-Scale Analysis of TCAR in The Treatment of Standard Surgical Risk Patients Presented at The Society for Vascular Surgery 2021 Vascular Annual Meeting

3 months ago - GlobeNewsWire

Silk Road Medical (SILK) Reports Q2 Loss, Tops Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of 16.22% and 4.45%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Silk Road Medical Reports Second Quarter 2021 Financial Results

SUNNYVALE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results...

4 months ago - GlobeNewsWire

Silk Road Medical Names Dr. Tanisha Carino to Board of Directors

SUNNYVALE, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has appo...

4 months ago - GlobeNewsWire

Analysts Estimate Silk Road Medical (SILK) to Report a Decline in Earnings: What to Look Out for

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

Silk Road Medical to Report Second Quarter 2021 Financial Results on July 29, 2021

SUNNYVALE, Calif., July 16, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report f...

4 months ago - GlobeNewsWire

First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular...

SUNNYVALE, Calif., July 06, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that key data re...

4 months ago - GlobeNewsWire

Silicon Valley-Based Silk Road Medical Announces Expansion to MSP Region

SUNNYVALE, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, recently announced the opening o...

5 months ago - GlobeNewsWire

Silk Road Medical (SILK) Reports Q1 Loss, Tops Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of 22.50% and 3.08%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Silk Road Medical: Q1 Earnings Insights

Shares of Silk Road Medical (NASDAQ:SILK) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 3.13% over the past year to ($0.31), which be...

6 months ago - Benzinga

Silk Road Medical Reports First Quarter 2021 Financial Results

SUNNYVALE, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results ...

6 months ago - GlobeNewsWire

Silk Road Medical to Present at BofA Securities 2021 Virtual Health Care Conference

SUNNYVALE, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will ...

7 months ago - GlobeNewsWire

Silk Road Medical to Report First Quarter 2021 Financial Results on May 4, 2021

SUNNYVALE, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report ...

7 months ago - GlobeNewsWire

Silk Road Medical Appoints William Hill as General Counsel

SUNNYVALE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the appointment...

7 months ago - GlobeNewsWire

New Strong Sell Stocks for March 25th

APG, FLR, ROCK, SILK, and CYD have been added to the Zacks Rank #5 (Strong Sell) List on March 25, 2021

Other symbols:APGCYDFLRROCK
8 months ago - Zacks Investment Research

Moving Average Crossover Alert: Silk Road Medical (SILK)

Silk Road Medical (SILK) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

8 months ago - Zacks Investment Research